SOCS3 inhibits TPO-stimulated, but not spontaneous, megakaryocytic growth in primary myelofibrosis

Saved in:
Bibliographic Details
Published inLeukemia Vol. 23; no. 6; pp. 1186 - 1190
Main Authors Chaligné, R, Tonetti, C, Besancenot, R, Marty, C, Kiladjian, J-J, Socié, G, Bordessoule, D, Vainchenker, W, Giraudier, S
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2009
Nature Publishing Group
Springer Nature
Subjects
Cancer Research
Cell Proliferation
Cellular signal transduction
Critical Care Medicine
DNA Methylation
Dosage and administration
Drug therapy
Enzyme inhibitors
Gene mutations
Genetic aspects
Health aspects
Hematology
Humans
Immunology
Intensive
Internal Medicine
letter-to-the-editor
Life Sciences
Medicine
Medicine & Public Health
Megakaryocytes
Megakaryocytes - pathology
Myelofibrosis
Oncology
Primary Myelofibrosis
Primary Myelofibrosis - pathology
Promoter Regions, Genetic
Risk factors
Suppressor of Cytokine Signaling 3 Protein
Suppressor of Cytokine Signaling Proteins
Suppressor of Cytokine Signaling Proteins - genetics
Suppressor of Cytokine Signaling Proteins - physiology
Thrombopoietin
Thrombopoietin - physiology
France
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2009.22